These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38622691)

  • 1. Macrophages as carriers of boron carbide nanoparticles dedicated to boron neutron capture therapy.
    Wróblewska A; Szermer-Olearnik B; Szczygieł A; Węgierek-Ciura K; Mierzejewska J; Kozień D; Żeliszewska P; Kruszakin R; Migdał P; Pędzich Z; Pajtasz-Piasecka E
    J Nanobiotechnology; 2024 Apr; 22(1):183. PubMed ID: 38622691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages as Promising Carriers for Nanoparticle Delivery in Anticancer Therapy.
    Wróblewska A; Szczygieł A; Szermer-Olearnik B; Pajtasz-Piasecka E
    Int J Nanomedicine; 2023; 18():4521-4539. PubMed ID: 37576466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boron-Rich Boron Carbide Nanoparticles as a Carrier in Boron Neutron Capture Therapy: Their Influence on Tumor and Immune Phagocytic Cells.
    Kozień D; Szermer-Olearnik B; Rapak A; Szczygieł A; Anger-Góra N; Boratyński J; Pajtasz-Piasecka E; Bućko MM; Pędzich Z
    Materials (Basel); 2021 Jun; 14(11):. PubMed ID: 34199341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Characterization of Boron Carbide Nanoparticles as Potential Boron-Rich Therapeutic Carriers.
    Kozień D; Żeliszewska P; Szermer-Olearnik B; Adamczyk Z; Wróblewska A; Szczygieł A; Węgierek-Ciura K; Mierzejewska J; Pajtasz-Piasecka E; Tokarski T; Cios G; Cudziło S; Pędzich Z
    Materials (Basel); 2023 Oct; 16(19):. PubMed ID: 37834671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyglycerol Functionalized
    Wang Y; Reina G; Kang HG; Chen X; Zou Y; Ishikawa Y; Suzuki M; Komatsu N
    Small; 2022 Sep; 18(37):e2204044. PubMed ID: 35983628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalization and cellular uptake of boron carbide nanoparticles. The first step toward T cell-guided boron neutron capture therapy.
    Mortensen MW; Björkdahl O; Sørensen PG; Hansen T; Jensen MR; Gundersen HJ; Bjørnholm T
    Bioconjug Chem; 2006; 17(2):284-90. PubMed ID: 16536457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of Boron carbide nanoparticles for use as a novel agent in T cell-guided boron neutron capture therapy.
    Mortensen MW; Sørensen PG; Björkdahl O; Jensen MR; Gundersen HJ; Bjørnholm T
    Appl Radiat Isot; 2006 Mar; 64(3):315-24. PubMed ID: 16290943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On-Demand Biodegradable Boron Nitride Nanoparticles for Treating Triple Negative Breast Cancer with Boron Neutron Capture Therapy.
    Li L; Li J; Shi Y; Du P; Zhang Z; Liu T; Zhang R; Liu Z
    ACS Nano; 2019 Dec; 13(12):13843-13852. PubMed ID: 31697475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray assisted toxicological investigations of boron carbide nanoparticles on human primary alveolar epithelial cells.
    Türkez H; Arslan ME; Sönmez E; Geyikoğlu F; Açıkyıldız M; Tatar A
    Chem Biol Interact; 2019 Feb; 300():131-137. PubMed ID: 30684454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan Coating Effect on Cellular Uptake of PLGA Nanoparticles for Boron Neutron Capture Therapy.
    Takeuchi I; Ariyama M; Makino K
    J Oleo Sci; 2019 Apr; 68(4):361-368. PubMed ID: 30867387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatibility of functionalized boron phosphate (BPO4) nanoparticles for boron neutron capture therapy (BNCT) application.
    Achilli C; Grandi S; Ciana A; Guidetti GF; Malara A; Abbonante V; Cansolino L; Tomasi C; Balduini A; Fagnoni M; Merli D; Mustarelli P; Canobbio I; Balduini C; Minetti G
    Nanomedicine; 2014 Apr; 10(3):589-97. PubMed ID: 24161383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipid-Coated Boronic Oxide Nanoparticles as Boron Agents for Boron Neutron Capture Therapy.
    Kawasaki R; Hirano H; Yamana K; Oshige A; Nishimura K; Kono N; Sanada Y; Bando K; Tabata A; Yasukawa N; Azuma H; Takata T; Sakurai Y; Tanaka H; Suzuki M; Tarutani N; Katagiri K; Nagasaki T; Ikeda A
    Chembiochem; 2023 Aug; 24(15):e202300186. PubMed ID: 37069129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo investigation of boron-rich nanodrugs for treating triple-negative breast cancers via boron neutron capture therapy.
    Lan KW; Huang WY; Chiu YL; Hsu FT; Chien YC; Hsiau YY; Wang TW; Keng PY
    Biomater Adv; 2023 Dec; 155():213699. PubMed ID: 37979440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Eradication by Boron Neutron Capture Therapy with
    Zhang Y; Kang HG; Xu HZ; Luo H; Suzuki M; Lan Q; Chen X; Komatsu N; Zhao L
    Adv Mater; 2023 Sep; 35(35):e2301479. PubMed ID: 37243974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular delivery and passive tumor targeting of a self-assembled nanogel containing carborane clusters for boron neutron capture therapy.
    Kawasaki R; Sasaki Y; Akiyoshi K
    Biochem Biophys Res Commun; 2017 Jan; 483(1):147-152. PubMed ID: 28039054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of boron cluster-containing redox nanoparticles with ROS scavenging ability in boron neutron capture therapy to achieve high therapeutic efficiency and low adverse effects.
    Gao Z; Horiguchi Y; Nakai K; Matsumura A; Suzuki M; Ono K; Nagasaki Y
    Biomaterials; 2016 Oct; 104():201-12. PubMed ID: 27467416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Characterization of Gd-Functionalized B
    Vitali A; Demichelis MP; Di Martino G; Postuma I; Bortolussi S; Falqui A; Milanese C; Ferrara C; Sommi P; Anselmi-Tamburini U
    Life (Basel); 2023 Feb; 13(2):. PubMed ID: 36836786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Detailed Study on using Novel LM 25 Aluminium Alloy Hybrid Metal Matrix Nanocomposite for Nuclear Applications.
    Naidu SCVRM; V S; Prabhu P; Hussain BI; Asary AR; Padmanaban G; Srinivasnaik M; Yuvaraj KP
    Recent Pat Nanotechnol; 2024 Mar; ():. PubMed ID: 38532601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-targeting with ultra-small nanoparticles: boron carbon dots as drug candidates for boron neutron capture therapy.
    Feiner IVJ; Pulagam KR; Uribe KB; Passannante R; Simó C; Zamacola K; Gómez-Vallejo V; Herrero-Álvarez N; Cossío U; Baz Z; Caffarel MM; Lawrie CH; Vugts DJ; Rejc L; Llop J
    J Mater Chem B; 2021 Jan; 9(2):410-420. PubMed ID: 33367431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boron-enriched polyvinyl-alcohol/boric-acid nanoparticles for boron neutron capture therapy.
    Chan WJ; Cho HL; Goudar V; Bupphathong S; Shu CH; Kung C; Tseng FG
    Nanomedicine (Lond); 2021 Mar; 16(6):441-452. PubMed ID: 33599549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.